Tuberculosis: a Persistent Health Challenge for India
Purpose of Review
Currently, India accounts for more than a quarter of incident TB cases globally. The Indian government recently announced a new national strategic plan to eliminate TB by 2025, but much is still unknown about the epidemic, in part due to a weakly regulated and highly privatized health sector. In this review, we provide an overview of the current landscape of TB in India, focusing on major challenges to elimination.
Historically, political will and investment in TB care in India have been lacking. To successfully eliminate TB, India will need to broadly improve the quality of care that TB patients receive. Simulated patient studies have shown that the current quality of care is poor, especially in the private sector where drug sales estimate over one million TB patients seek care annually. Cascade of care studies indicate that TB patients are lost at every stage of care-seeking. Access is suboptimal for new diagnostic technologies such as GeneXpert and new drugs such as bedaquiline. Additionally, research in the social determinants of health indicates that factors such as undernutrition, smoking, and diabetes are major driving forces behind the TB epidemic.
India’s ambitious plan for TB elimination will require strong political and financial commitment to move forward. In order to effectively tackle TB, the Indian government needs to better engage the private sector and focus on quality: quality of care for patients, quality improvement of TB programs, and overall health quality to address social determinants.
KeywordsTuberculosis India Global health Quality of care Operational research Epidemiology
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.World Health Organization. Global tuberculosis report. 2017 Geneva.Google Scholar
- 3.Mistry N, Lobo E, Shah S, Rangan S, Dholakia Y. Pulmonary tuberculosis in Patna, India: durations, delays, and health care seeking behaviour among patients identified through household surveys. J Epidemiol Glob Health. 2017;7(4):241–8. https://doi.org/10.1016/j.jegh.2017.08.001.CrossRefPubMedGoogle Scholar
- 4.• Sreeramareddy CT, Qin ZZ, Satyanarayana S, Subbaraman R, Pai M. Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis. 2014;18(3):255–66. Systematically reviews available literature to show a median patient delay of > 2 weeks and a diagnostic delay of > 1 month for Indian TB patients. Such delays increase transmission and the risk of death. https://doi.org/10.5588/ijtld.13.0585.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.•• Subbaraman R, Nathavitharana RR, Satyanarayana S, Pai M, Thomas BE, Chadha VK, et al. The tuberculosis cascade of care in India’s public sector: a systematic review and meta-analysis. PLoS Med. 2016;13(10):e1002149. Systematically reviews available literature to characterize the public sector TB patient care cascade. The results show staggering losses at each step of the cascade with nearly half of patients being lost to follow up before treatment initiation. https://doi.org/10.1371/journal.pmed.1002149.CrossRefPubMedPubMedCentralGoogle Scholar
- 6.•• Das J, Kwan A, Daniels B, Satyanarayana S, Subbaraman R, Bergkvist S, et al. Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study. Lancet Infect Dis. 2015;15(11):1305–13. The first application of the standardised patient (SP) methodology to TB. SPs allow for assessment of the real world care patients receive. This work showed that private physicians were failing to correctly manage the majority of TB cases presented to them. https://doi.org/10.1016/S1473-3099(15)00077-8.CrossRefPubMedPubMedCentralGoogle Scholar
- 7.• Satyanarayana S, Kwan A, Daniels B, Subbaraman R, McDowell A, Bergkvist S, et al. Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: a cross-sectional study. Lancet Infect Dis. 2016;16(11):1261–8. The same TB SP methodology was applied to Indian pharmacists. This work showed that TB patients were frequently being prescribed non-specific antibiotics but not anti-TB medication. https://doi.org/10.1016/S1473-3099(16)30215-8.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.World Health Organization. The end TB strategy: global strategy and targets for tuberculosis prevention, care, and control after 2015. 2015 Geneva.Google Scholar
- 9.•• Revised National Tuberculosis Control Programme. National strategic plan for tuberculosis elimination 2017–2025. 2017. https://tbcindia.gov.in/WriteReadData/NSP%20Draft%2020.02.2017%201.pdf. Accessed 21 Jan 2018. This NSP outlines the RNTCP’s ambitious goal of TB elimination by 2025. It outlines many admirable programs and goalposts but the question remains whether this is enough will and funding to fully execute it.
- 10.Registrar General of India, Centre for Global Health Research. A joint report of the registrar General of India and the Centre for Global Health Research: causes of death statistics 2010–2013. 2015. http://www.cghr.org/wordpress/wp-content/uploads/COD-India-Report-2010-2013-Dec-19-2015.pdf. Accessed 21 Jan 2018.
- 11.Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544. https://doi.org/10.1016/S0140-6736(16)31012-1.CrossRefGoogle Scholar
- 15.Fullman N, Barber RM, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Measuring progress and projecting attainment on the basis of past trends of the health-related sustainable development goals in 188 countries: an analysis from the global burden of disease study 2016. Lancet. 2017;390:1423–59. https://doi.org/10.1016/S0140-6736(17)32336-X.CrossRefGoogle Scholar
- 16.Government of India Cabinet. National Health Policy, 2017 approved by cabinet focus on preventive and promotive health care and universal access to good quality health care services [Press release]. 2017.Google Scholar
- 18.Krishnan V. Women survivors who won over TB—The Hindu. The Hindu. 2017.Google Scholar
- 19.Sherlal J. Amitabh Bachchan: I suffered from TB in 2000. Time India. 2014.Google Scholar
- 20.Krishnan V. India’s refusal to scale up bedaquiline is really the world’s problem. The Hindu. 2017.Google Scholar
- 21.Central TB Division, Government of India. TB India 2017. 2017.Google Scholar
- 22.Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D’Ambrosio L, Centis R, et al. Effectiveness and safety of bedaquilinecontaining regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J. 2017;49(5):1700387. https://doi.org/10.1183/13993003.00387-2017.CrossRefPubMedGoogle Scholar
- 24.Pai M, Furin J. Tuberculosis innovations mean little if they cannot save lives. Elife. 2017;6 https://doi.org/10.7554/eLife.25956.001.
- 25.•• Arinaminpathy N, Batra D, Khaparde S, Vualnam T, Maheshwari N, Sharma L, et al. The number of privately treated tuberculosis cases in India: an estimation from drug sales data. Lancet Infect Dis. 2016;16(11):1255–60. Drug sale data was used, for the first time, to estimate the number of TB patients being treated outside the RNTCP. The estimate caused a large upward revision to the estimated TB burden in India and catalyzed efforts to engage the private sector. https://doi.org/10.1016/S1473-3099(16)30259-6.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.World Health Organization. Global tuberculosis report. Geneva. 2016.Google Scholar
- 27.• Satyanarayana S, Nair SA, Chadha SS, Shivashankar R, Sharma G, Yadav S, et al. From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PLoS One. 2011;6(9):e24160. This large community-based door-to-door survey estimated that 46% of TB patients were receiving care outside the RNTCP. https://doi.org/10.1371/journal.pone.0024160.CrossRefPubMedPubMedCentralGoogle Scholar
- 31.How India is moving the needle on TB. In: Bill Melinda Gates Found. 2015 https://www.impatientoptimists.org/Posts/2015/01/How-India-is-moving-the-needle-on-TB#.WfopqBNSxE4. Accessed 1 Nov 2017.
- 33.IPAQT Initiative for Promoting Affordable & Quality TB Tests. http://ipaqt.org/. Accessed 1 Apr 2016.
- 34.•• Clinton Health Access Initiative. Catalyzing India’s private sector market for accurate TB testing. 2016. https://clintonhealthaccess.org/content/uploads/2016/06/Case-Study-India-IPAQT-June-2016.pdf. Accessed 21 Jan 2018. Clinton Health Access Initiative negotiated with private sector labs and diagnostics companies to provide WHO-endorsed TB diagnostics to the private labs at public sector pricing while enforcing a consumer price ceiling. This allowed increased use of high quality diagnostics in the private sector where they have previously been prohibitively expensive.
- 35.Sharma A, Hill A, Kurbatova E, van der Walt M, Kvasnovsky C, Tupasi TE, et al. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study. Lancet Infect Dis. 2017;17(7):707–15. https://doi.org/10.1016/S1473-3099(17)30247-5.CrossRefPubMedGoogle Scholar
- 36.Sachdeva KS, Raizada N, Sreenivas A, van't Hoog AH, van den Hof S, Dewan PK, et al. Use of Xpert MTB/RIF in decentralized public health settings and its effect on pulmonary TB and DR-TB case finding in India. PLoS One. 2015;10(5):e0126065. https://doi.org/10.1371/journal.pone.0126065.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Cazabon D, Alsdurf H, Satyanarayana S, Nathavitharana R, Subbaraman R, Daftary A, et al. Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade. Int J Infect Dis. 2017;56:111–6. https://doi.org/10.1016/j.ijid.2016.10.016.CrossRefPubMedGoogle Scholar
- 46.•• Dandona L, Dandona R, Kumar GA, Shukla DK, Paul VK, Balakrishnan K, et al. Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. Lancet. 2017;390(10111):2437–60. https://doi.org/10.1016/S0140-6736(17)32804-0. As a part of the Global Burden of Disease Study, disease burden and risk factor prevelances were estimated for all states in India. This is the first instance of comprehensive, high quality, and granular estimates being available for individual Indian states. The estimates highlight the heterogeneity within India and its progression through the epidemiological transition. CrossRefGoogle Scholar
- 48.• Oxlade O, Huang CC, Murray M. Estimating the impact of reducing under-nutrition on the tuberculosis epidemic in the central eastern states of India: a dynamic modeling study. PLoS One. 2015;10(6):e0128187. This modelling study highlighted the drastic impact that ameliorating nutritional status could have on TB rates in India. https://doi.org/10.1371/journal.pone.0128187.CrossRefPubMedPubMedCentralGoogle Scholar
- 50.Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5(8):585–96. https://doi.org/10.1016/S2213-8587(17)30174-2.CrossRefPubMedGoogle Scholar
- 51.Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5:1091–101.Google Scholar
- 53.Viswanathan V, Kumpatla S, Aravindalochanan V, Rajan R, Chinnasamy C, Srinivasan R, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One. 2012;7(7):e41367. https://doi.org/10.1371/journal.pone.0041367.CrossRefPubMedPubMedCentralGoogle Scholar
- 54.Agarwal AK, Gupta G, Marskole P, Agarwal A. A study of the patients suffering from tuberculosis and tuberculosis-diabetes comorbidity in Revised National Tuberculosis Control Program Centers of Northern Madhya Pradesh, India. Indian J Endocrinol Metab. 2017;21(4):570–6. https://doi.org/10.4103/ijem.IJEM_89_17.CrossRefPubMedPubMedCentralGoogle Scholar